Therapeutic and prophylactic effects of oral administration of probiotic Enterococcus faecium Smr18 in Salmonella enterica-infected mice
Open Access
- 18 May 2023
- journal article
- research article
- Published by Springer Nature in Gut Pathogens
- Vol. 15 (1) , 1-14
Abstract
Salmonella enterica serotype Typhi causes chronic enteric fever known as typhoid. Prolonged treatment regimen used for the treatment of typhoid and indiscriminate use of antibiotics has led to the emergence of resistant strains of S. enterica that has further increased the severity of the disease. Therefore, alternative therapeutic agents are urgently required. In this study, probiotic and enterocin-producing bacteria Enterococcus faecium Smr18 was compared for both its prophylactic and therapeutic efficacy in S. enterica infection mouse model. E. faecium Smr18 possessed high tolerance to bile salts and simulated gastric juice, as treatment for 3 and 2 h resulted in 0.5 and 0.23 log10 reduction in the colony forming units, respectively. It exhibited 70% auto aggregation after 24 h of incubation and formed strong biofilms at both pH 5 and 7. Oral administration of E. faecium in BALB/c mice infected with S. enterica significantly (p < 0.05) reduced the mortality of the infected mice and prevented the weight loss in mice. Administration of E. faecium prior to infection inhibited the translocation of S. enterica to liver and spleen, whereas, its administration post-infection completely cleared the pathogen from the organs within 8 days. Further, in both pre- and post-E. faecium-treated infected groups, sera levels of liver enzymes were restored back to normal; whereas the levels of creatinine, urea and antioxidant enzymes were significantly (p < 0.05) reduced compared to the untreated-infected group. E. faecium Smr18 administration significantly increased the sera levels of nitrate by 1.63-fold and 3.22-fold in pre- and post-administration group, respectively. Sera levels of interferon-γ was highest (tenfold) in the untreated-infected group, whereas the levels of interleukin-10 was highest in the post-infection E. faecium-treated group thereby indicating the resolution of infection in the probiotic-treated group, plausibly due to the increased production of reactive nitrogen intermediates.Keywords
This publication has 82 references indexed in Scilit:
- Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in miceBMC Microbiology, 2011
- Lactobacillus plantarum (VR1) isolated from an Ayurvedic medicine (Kutajarista) ameliorates in vitro cellular damage caused by Aeromonas veroniiBMC Microbiology, 2011
- Identification of genes differentially expressed during interaction of Mexican lime tree infected with "Candidatus Phytoplasma aurantifolia"BMC Microbiology, 2011
- Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian childrenBMC Infectious Diseases, 2010
- Imported Enteric Fever: Case Series from the Hospital for Tropical Diseases, London, United KingdomThe American Journal of Tropical Medicine and Hygiene, 2010
- Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damageFEMS Microbiology Ecology, 2009
- Biochemical and antimicrobial profile ofEnterococcus faeciumandE. faecalisisolated from traditional dairy products and infant intestinal microbiotaMicrobial Ecology in Health and Disease, 2009
- Infant intestinal Enterococcus faecalis down-regulates infl ammatory responses in human intestinal cell linesWorld Journal of Gastroenterology, 2008
- Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurementsFEMS Microbiology Letters, 1992
- Precise Estimation of the Numbers of Chronic Carriers of Salmonella typhi in Santiago, Chile, an Endemic AreaThe Journal of Infectious Diseases, 1982